Moleculin Biotech (MBRX) Tops Q1 EPS by 1c

Moleculin Biotech (NASDAQ: MBRX) reported Q1 EPS of ($0.28), $0.01 better than the analyst estimate of ($0.29).

For earnings history and earnings-related data on Moleculin Biotech (MBRX) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Goldman "broadly" raises estimates for LTL and truckload stocks
• UBS Reiterates Buy Rating on General Motors (GM) as Defense Opportunity in Focus